Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- 2014 Ebola outbreak in West Africa (1)
- AZT trials (1)
- Alien Tort Statute (1)
- Anthropology and law (1)
- Anti-money laundering (1)
-
- Bank Secrecy Act (1)
- Banking services (1)
- Baptists and Bootleggers (1)
- Biologics (1)
- Biosimilars (1)
- CDC (1)
- Cannabis (1)
- Center for Disease Control (1)
- Controlled Substances Act (1)
- Council of the International Organization of Medical Sciences (1)
- Declaration of Helsinki (1)
- Decriminalization (1)
- Department of Health and Human Services (1)
- Disclosure labels (1)
- Disruptive innovation (1)
- Dr. Kent Brantly (1)
- Ebola Virus Disease (1)
- Ebola vaccines (1)
- Emory University Hospital (1)
- Experimental drug use (1)
- Experimental medicine (1)
- FDA (1)
- Federal Drug Administration (1)
- Federal Reserve (1)
- Financial cooperatives (1)
- Publication
- Publication Type
Articles 1 - 7 of 7
Full-Text Articles in Food and Drug Law
Ebola, Experimental Medicine, Economics, And Ethics: An Evaluation Of International Disease Outbreak Law, Sara L. Dominey
Ebola, Experimental Medicine, Economics, And Ethics: An Evaluation Of International Disease Outbreak Law, Sara L. Dominey
Georgia Journal of International & Comparative Law
No abstract provided.
3d-Printed Food, Jasper L. Tran
3d-Printed Food, Jasper L. Tran
Minnesota Journal of Law, Science & Technology
No abstract provided.
Despite What You've Been Sold - Unwrapping The Falsities Surounding Food Labels, Camille Currey
Despite What You've Been Sold - Unwrapping The Falsities Surounding Food Labels, Camille Currey
West Virginia Law Review
No abstract provided.
Manufacturing Barriers To Biologics Competition And Innovation, W. Nicholson Price Ii., Arti K. Rai
Manufacturing Barriers To Biologics Competition And Innovation, W. Nicholson Price Ii., Arti K. Rai
Articles
As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to "large molecule" biologics. Although biologics represent many of the most promising new therapies for previously intractable diseases, they are extremely expensive. Moreover, the pathway for generic-type competition set up by Congress in 2010 is unlikely to yield significant cost savings. This Article provides a fresh diagnosis of and prescription for this major public policy problem. It argues that the key cause is pervasive trade secrecy in the complex area of biologics manufacturing. Under the current regime, this trade secrecy, combined with certain features of Food and …
Underbanked: Cooperative Banking As A Potential Solution To The Marijuana-Banking Problem, Patrick A. Tighe
Underbanked: Cooperative Banking As A Potential Solution To The Marijuana-Banking Problem, Patrick A. Tighe
Michigan Law Review
Numerous states have recently legalized recreational marijuana, which has created a burgeoning marijuana industry needing and demanding access to a variety of banking and financial services. Due, however, to the interplay between the federal criminalization of marijuana and federal anti-money laundering laws, U.S. financial institutions cannot handle legally the proceeds from marijuana activity. As a result, most financial institutions are unwilling to flout federal anti-money laundering laws, and so too few marijuana-related businesses can access banking services. This Note argues that the most viable policy option for resolving this “underbanking” problem is a financial cooperative approach such as a cannabis-only …
The Food And Drug Administration Versus The Federal Trade Commission: Reconciling Their Interests In Regulating Homeopathic Products, 49 J. Marshall L. Rev. 1193 (2016), Jordannah Bangi
UIC Law Review
This Comment suggests that the FDA should require homeopathic products to carry a disclaimer label similar to those used on prescription drugs or certain food or food products.
Incumbent Landscapes, Disruptive Uses: Perspectives On Marijuana-Related Land Use Control, Donald J. Kochan
Incumbent Landscapes, Disruptive Uses: Perspectives On Marijuana-Related Land Use Control, Donald J. Kochan
Donald J. Kochan